These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26491887)

  • 21. Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs?
    Chen JQ; Contreras RG; Wang R; Fernandez SV; Shoshani L; Russo IH; Cereijido M; Russo J
    Breast Cancer Res Treat; 2006 Mar; 96(1):1-15. PubMed ID: 16322895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
    Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into the regulation of Na+,K+-ATPase by ouabain.
    Silva E; Soares-da-Silva P
    Int Rev Cell Mol Biol; 2012; 294():99-132. PubMed ID: 22364872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
    Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
    Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitomycin C and doxorubicin elicit conflicting signals by causing accumulation of cyclin E prior to p21WAF1/CIP1 elevation in human hepatocellular carcinoma cells.
    Choi SY; Shen YN; Woo SR; Yun M; Park JE; Ju YJ; Jeong J; Shin HJ; Joo HY; Park ER; Lee JK; Kim SH; Cho MH; Kong IS; Lee KH
    Int J Oncol; 2012 Jan; 40(1):277-86. PubMed ID: 21887464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.
    Murphy D; Detjen KM; Welzel M; Wiedenmann B; Rosewicz S
    Hepatology; 2001 Feb; 33(2):346-56. PubMed ID: 11172336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PGE2 upregulates the Na+/K+ ATPase in HepG2 cells via EP4 receptors and intracellular calcium.
    Hodeify R; Chakkour M; Rida R; Kreydiyyeh S
    PLoS One; 2021; 16(1):e0245400. PubMed ID: 33444342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression.
    Zhang X; Jia S; Yang S; Yang Y; Yang T; Yang Y
    J Cell Biochem; 2012 Nov; 113(11):3528-35. PubMed ID: 22730174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA.
    Zhang J; Ishigaki Y; Takegami T
    Mol Med Rep; 2015 Oct; 12(4):5109-15. PubMed ID: 26151503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
    Gentile DA; Skoner DP
    Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway.
    Wu M; Zhou Y; Fei C; Chen T; Yin X; Zhang L; Ren Z
    Int J Oncol; 2020 Sep; 57(3):845-857. PubMed ID: 32705157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
    Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
    Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation.
    Nguyen AN; Wallace DP; Blanco G
    J Am Soc Nephrol; 2007 Jan; 18(1):46-57. PubMed ID: 17151336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
    Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
    Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential activation of mitogen-activated protein kinases by palytoxin and ouabain, two ligands for the Na+,K+-ATPase.
    Li S; Wattenberg EV
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):377-84. PubMed ID: 9707514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
    Veklich TO; Shkrabak OA; Kosterin SO; Rodik RV; Cherenok SO; Boĭko SO; Boĭko VI; Kal'chenko VI
    Ukr Biokhim Zh (1999); 2006; 78(6):53-63. PubMed ID: 17494319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.